Perioperative Fluid Therapy in Patients Undergoing Pancreaticoduodenectomy
1 other identifier
observational
168
0 countries
N/A
Brief Summary
Postoperative complication rates in patients undergoing pancreaticoduodenectomy remain high although the operation techniques have developed a lot in recent years. There is evidence that restrictive intraoperative fluid therapy could decrease postoperative complication rates but the results of the former studies have been somewhat controversial. The aim of this study is to examine whether the intraoperative and postoperative fluid therapy affect to the postoperative complication rates in patients undergoing pancreaticoduodenectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2015
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2020
CompletedFirst Submitted
Initial submission to the registry
December 20, 2020
CompletedFirst Posted
Study publicly available on registry
December 29, 2020
CompletedDecember 29, 2020
December 1, 2020
3 years
December 20, 2020
December 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Intraoperative fluid volume
The amount of fluid (crystalloids and albumin) patients got during the surgery
The duration of the surgery
Postoperative complications (Clavien-Dindo classification)
The rate of severe Clavien-Dindo complications (3-5)
Postoperative day 0-30
Secondary Outcomes (6)
Severe surgical complications
Postoperative day 0-30
Cardiopulmonary complications
Postoperative day 0-30
Pancreatic fistulas
Postoperative day 0-30
Postoperative fluid volume
Postoperative day 0-3
Intraoperative fluid balance
The duration of the surgery
- +1 more secondary outcomes
Study Arms (2)
Pancreaticoduodenectomy in 2015
Patients who underwent pancreaticoduodenectomy in 2015 got intraoperative fluid therapy in goal directed fluid therapy technique. Most of the patients spent the first postoperative night in ICU where the monitoring of urine output and fluid balance are more specific than in a normal ward.
Pancreaticoduodenectomy in 2017
Patients who underwent pancreaticoduodenectomy in 2017 got liberal intraoperative fluid therapy and most of the patients spent the first postoperative night in a regular ward.
Interventions
Patients in 2015 got intraoperative fluid therapy in goal directed fluid therapy technique.
Patients in 2017 got liberal intraoperative fluid therapy influenced by their anaesthesiologist.
Eligibility Criteria
All patients who have underwent pancreaticoduodenectomy in years 2015 and 2017 are counted in the study.
You may qualify if:
- age 18 or over
- patients who underwent pancreaticoduodenectomy in 2015 or in 2017
You may not qualify if:
- patients whose patient record information is insufficient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Piia Peltoniemi, M.D.
Helsinki University Central Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D. Principal Investigator
Study Record Dates
First Submitted
December 20, 2020
First Posted
December 29, 2020
Study Start
January 1, 2015
Primary Completion
December 31, 2017
Study Completion
November 20, 2020
Last Updated
December 29, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share